Intimate partner violence and cognitive functioning - toward quantifying dementia risk
View abstract on PubMed
Summary
This summary is machine-generated.Intimate partner violence (IPV) is linked to lower average cognitive scores in women. Emotional abuse showed the strongest association with cognitive decline, highlighting the impact of gendered experiences on dementia risk.
Area Of Science
- Neuroscience
- Public Health
- Sociology
Background
- Intimate partner violence (IPV) is a prevalent issue among women.
- IPV is associated with adverse health outcomes, potentially increasing dementia risk.
Purpose Of The Study
- To investigate the association between intimate partner violence (IPV) victimization and cognitive function in aging women.
- To explore the impact of different IPV subtypes on cognitive performance and cognitive change.
Main Methods
- Utilized data from 14,771 participants in the Nurses' Health Study II.
- Assessed emotional, physical, and sexual IPV reported in adulthood.
- Evaluated cognitive function using the Cogstate Brief Battery from 2014-2019.
Main Results
- IPV was associated with a lower average global cognitive score (0.029 SD units).
- Emotional IPV demonstrated the strongest negative association with cognitive scores (β = -0.048).
- No significant difference in the rate of cognitive change was observed based on violence exposure.
Conclusions
- Gendered social experiences like IPV may influence dementia risk.
- IPV, particularly emotional abuse, is linked to lower cognitive scores in aging women.
- Further research on IPV in aging cohorts is crucial for understanding dementia risk.
Related Concept Videos
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
What do you think is the single most influential factor in determining with whom you become friends and whom you form romantic relationships? You might be surprised to learn that the answer is simple: the people with whom you have the most contact. This most important factor is proximity. You are more likely to be friends with people you have regular contact with. For example, there are decades of research that shows that you are more likely to become friends with people who live in your dorm,...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

